Profile
Said Saim formerly worked at Collegium Pharmaceutical, Inc., as Senior Director-Pharmaceutical Development from 2008 to 2013, Boehringer Ingelheim Pharmaceuticals, Inc., as Principal Scientist, Higuchi Bioscience Center, as Assistant Research Professor, and EyePoint Pharmaceuticals, Inc., as Chief Technology Officer & Senior VP from 2019 to 2024.
Dr. Saim received his graduate degree and doctorate degree from the University of Kansas.
Former positions of Said Saim
| Companies | Position | End |
|---|---|---|
| EYEPOINT, INC. | Chief Tech/Sci/R&D Officer | 01/12/2024 |
Higuchi Bioscience Center | Corporate Officer/Principal | - |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Corporate Officer/Principal | - |
| COLLEGIUM PHARMACEUTICAL, INC. | Corporate Officer/Principal | - |
Training of Said Saim
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
University of Kansas
University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Higuchi Bioscience Center |
- Stock Market
- Insiders
- Said Saim
















